Product Added to Cart!
N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine|31886|58970-76-6

N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine

$560.80

FREE
SHIPPING

100% MONEY
BACK GUARANTEE

ONLINE
SUPPORT 24/7

Available on backorder. Please allow 4-6 weeks for production.
Sku CI31886_1_G
Chem Impex
Get Bulk Quote

Product Information

Product Name
N-(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl-L-leucine
Brand Name
Chem Impex
Product Number
31886
CAS
58970-76-6
Certificate of Analysis (COA)​
COA not found

General Information

PubChem CID
72172
IUPAC Name
(2S)-2-(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoylamino-4-methylpentanoic acid
InChI Key
VGGGPCQERPFHOB-RDBSUJKOSA-N
SMILES
CC(C)CC@@H(C(=O)O)NC(=O)C@H(C@@H(CC1=CC=CC=C1)N)O

Description

N-(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl-L-leucine is widely utilized in research focused on:

Pharmaceutical Development: This compound serves as a key intermediate in the synthesis of peptide-based drugs, particularly those targeting metabolic disorders.

Biotechnology: It is used in the formulation of biologically active peptides, enhancing their stability and efficacy in therapeutic applications.

Nutrition Science: The compound is explored for its potential benefits in sports nutrition, particularly in formulations aimed at muscle recovery and growth.

Cosmetic Industry: It finds application in skincare products due to its amino acid profile, which can help improve skin hydration and elasticity.

Research on Neuroprotective Agents: The compound is being studied for its potential neuroprotective properties, making it relevant in the development of treatments for neurodegenerative diseases.

References Data Source From Pubchem

Ubenimex synergizes with the PD-L1 blockade in gastric cancer by competitively binding LAP3 with UBE3A
Publication Name: Cell Death & Disease
Publication Date: 2026-02-26
DOI: 10.1038/s41419-026-08509-3

The moonlighting functions of glycolytic enzymes in tumorigenesis
Publication Name: Cellular oncology (Dordrecht, Netherlands)
Publication Date: 2026-02-02
DOI: 10.1007/s13402-025-01135-9

Pretangle tau pathology accrual in the default mode network during the progression of Alzheimer’s disease
Publication Name: Molecular Neurodegeneration Advances
Publication Date: 2026-01-27
DOI: 10.1186/s44477-026-00019-y

Redox Perturbation in Cadmium-Mediated Hypothalamic, Pituitary, and Testicular Impairment and Protective Effects of Zinc in Rats Is Accompanied by Modulation of Tryptophan Catabolism Enzyme/Protein
Publication Name: Molecular Neurobiology
Publication Date: 2026-01-25
DOI: 10.1007/s12035-026-05689-z

CD36 regulates myogenic differentiation via chronic integrated stress response – implications for muscle aging
Publication Name: Journal of Muscle Research and Cell Motility
Publication Date: 2026-01-22
DOI: 10.1007/s10974-025-09719-6